These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 17575164)
41. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
42. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Man K; Ng KT; Lo CM; Ho JW; Sun BS; Sun CK; Lee TK; Poon RT; Fan ST Liver Transpl; 2007 Dec; 13(12):1669-77. PubMed ID: 18044786 [TBL] [Abstract][Full Text] [Related]
43. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation. Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445 [TBL] [Abstract][Full Text] [Related]
44. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
45. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. Gouwy M; Ruytinx P; Radice E; Claudi F; Van Raemdonck K; Bonecchi R; Locati M; Struyf S PLoS One; 2016; 11(11):e0166006. PubMed ID: 27828999 [TBL] [Abstract][Full Text] [Related]
46. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
47. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Koga M; Kai H; Egami K; Murohara T; Ikeda A; Yasuoka S; Egashira K; Matsuishi T; Kai M; Kataoka Y; Kuwano M; Imaizumi T Biochem Biophys Res Commun; 2008 Jan; 365(2):279-84. PubMed ID: 17991428 [TBL] [Abstract][Full Text] [Related]
48. Studies on MIP-2 and CXCR2 expression in a mouse model of extrahepatic colorectal metastasis. Kollmar O; Junker B; Rupertus K; Menger MD; Schilling MK Eur J Surg Oncol; 2007 Aug; 33(6):803-11. PubMed ID: 17314027 [TBL] [Abstract][Full Text] [Related]
49. Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells. Kaczor DM; Kramann R; Hackeng TM; Schurgers LJ; Koenen RR Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054772 [TBL] [Abstract][Full Text] [Related]
53. The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction. Li J; Liu B; Yan LN; Lau WY Cytokine Growth Factor Rev; 2015 Feb; 26(1):67-74. PubMed ID: 25466649 [TBL] [Abstract][Full Text] [Related]
54. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. Petersen F; Bock L; Flad HD; Brandt E J Immunol; 1998 Oct; 161(8):4347-55. PubMed ID: 9780212 [TBL] [Abstract][Full Text] [Related]
55. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Strieter RM; Belperio JA; Burdick MD; Sharma S; Dubinett SM; Keane MP Ann N Y Acad Sci; 2004 Dec; 1028():351-60. PubMed ID: 15650260 [TBL] [Abstract][Full Text] [Related]
56. Shiquandabutangjiaweibang inhibits tumor metastasis and angiogenesis via regulation of topoisomerase-1. Kim SH; Lee TH; Yang DC; Kim HM; Kim JB; Park MK; Bae YS J Ethnopharmacol; 2005 Apr; 98(1-2):157-62. PubMed ID: 15763377 [TBL] [Abstract][Full Text] [Related]
57. Structural Properties of CXCL4L1 and Its Recognition of the CXCR3 N-Terminus. Liu YH; Chuang CH; Lee YZ; Lee ET; Lo CL; Wu CY; Huang LK; Bikfalvi A; Sue SC Biochemistry; 2023 Feb; 62(3):722-734. PubMed ID: 36626574 [TBL] [Abstract][Full Text] [Related]
58. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation. Brandhofer M; Hoffmann A; Blanchet X; Siminkovitch E; Rohlfing AK; El Bounkari O; Nestele JA; Bild A; Kontos C; Hille K; Rohde V; Fröhlich A; Golemi J; Gokce O; Krammer C; Scheiermann P; Tsilimparis N; Sachs N; Kempf WE; Maegdefessel L; Otabil MK; Megens RTA; Ippel H; Koenen RR; Luo J; Engelmann B; Mayo KH; Gawaz M; Kapurniotu A; Weber C; von Hundelshausen P; Bernhagen J Cell Mol Life Sci; 2022 Sep; 79(10):512. PubMed ID: 36094626 [TBL] [Abstract][Full Text] [Related]
59. Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma. Tominaga M; Iwashita Y; Ohta M; Shibata K; Ishio T; Ohmori N; Goto T; Sato S; Kitano S Cancer Gene Ther; 2007 Aug; 14(8):696-705. PubMed ID: 17514193 [TBL] [Abstract][Full Text] [Related]
60. CXCR3, a double-edged sword in tumor progression and angiogenesis. Billottet C; Quemener C; Bikfalvi A Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]